The inhibition of matrix metalloproteinase activity in chronic wounds by a polyacrylate superabsorber

Biomaterials

Volumn 29, Issue 19, 2008, Pages 2932-2940

  Eming, Sabine ^a   Smola, Hans ^a,b   Hartmann, Berenike ^a   Malchau, Gebhart ^a   Wegner, Ronny ^b   Krieg, Thomas ^a   Smola Hess, Sigrun ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Paul Hartmann AG   (Germany)

Author keywords

Absorption; Connective tissue; Matrix metalloproteinase; Polyacrylic acid; Wound dressing; Wound healing

Indexed keywords

ABSORPTION; BINDING SITES; ENZYME ACTIVITY; PEPTIDES;

CONNECTIVE TISSUE; MATRIX METALLOPROTEINASE; POLYACRYLIC ACID; WOUND DRESSING; WOUND HEALING;

ENZYME INHIBITION;

CALCIUM ION; CYTOKINE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; POLYACRYLIC ACID; ZINC ION;

AGED; ARTICLE; BINDING COMPETITION; CASE REPORT; CONTROLLED STUDY; DEGRADATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME SUBSTRATE; GRANULATION TISSUE; HUMAN; LEG ULCER; MICROENVIRONMENT; PRIORITY JOURNAL; PROTEIN DEGRADATION; WOUND; WOUND DRESSING; WOUND FLUID; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ACRYLIC RESINS; CHRONIC DISEASE; HUMANS; HYDROGEN-ION CONCENTRATION; MATRIX METALLOPROTEINASES; PROTEASE INHIBITORS; WOUNDS AND INJURIES;

EID: 42249090193     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.03.029     Document Type: Article

References (37)

1. Athanasopoulos A.N., Economopoulou M., Orlova V.V., Sobke A., Schneider D., Weber H., et al. The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms. Blood 107 (2006) 2720-2727
2. Baker E.A., and Leaper D.J. Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Wound Repair Regen 8 (2000) 392-398
3. Seah C.C., Phillips T.J., Howard C.E., Panova I.P., Hayes C.M., Asandra A.S., et al. Chronic wound fluid suppresses proliferation of dermal fibroblasts through a Ras-mediated signaling pathway. J Invest Dermatol 124 (2005) 466-474
4. Wlaschek M., and Scharffetter-Kochanek K. Oxidative stress in chronic venous leg ulcers. Wound Repair Regen 13 (2005) 452-461
5. Wysocki A.B., Staiano-Coico L., and Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101 (1993) 64-68
6. James T.J., Hughes M.A., Cherry G.W., and Taylor R.P. Evidence of oxidative stress in chronic venous ulcers. Wound Repair Regen 11 (2003) 172-176
7. Lauer G., Sollberg S., Cole M., Flamme I., Sturzebecher J., Mann K., et al. Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol 115 (2000) 12-18
8. Palolahti M., Lauharanta J., Stephens R.W., Kuusela P., and Vaheri A. Proteolytic activity in leg ulcer exudate. Exp Dermatol 2 (1993) 29-37
9. Trengove N.J., Bielefeldt-Ohmann H., and Stacey M.C. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 8 (2000) 13-25
10. Wysocki A.B., and Grinnell F. Fibronectin profiles in normal and chronic wound fluid. Lab Invest 63 (1990) 825-831
11. Trengove N.J., Stacey M.C., MacAuley S., Bennett N., Gibson J., Burslem F., et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 7 (1999) 442-452
12. Gill S.E., and Parks W.C. Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol (2007) 10.1016/j.biocel.2007.10.024
13. Vu T.H., and Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 14 (2000) 2123-2133
14. Ito A., Mukaiyama A., Itoh Y., Nagase H., Thogersen I.B., Enghild J.J., et al. Degradation of interleukin 1beta by matrix metalloproteinases. J Biol Chem 271 (1996) 14657-14660
15. Lee S., Jilani S.M., Nikolova G.V., Carpizo D., and Iruela-Arispe M.L. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 169 (2005) 681-691
16. McQuibban G.A., Gong J.H., Tam E.M., McCulloch C.A., Clark-Lewis I., and Overall C.M. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289 (2000) 1202-1206
17. Schonbeck U., Mach F., and Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol 161 (1998) 3340-3346
18. Yu Q., and Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14 (2000) 163-176
19. Hubner G., Brauchle M., Smola H., Madlener M., Fassler R., and Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 8 (1996) 548-556
20. Pilcher B.K., Dumin J., Schwartz M.J., Mast B.A., Schultz G.S., Parks W.C., et al. Keratinocyte collagenase-1 expression requires an epidermal growth factor receptor autocrine mechanism. J Biol Chem 274 (1999) 10372-10381
21. Varelias A., Cowin A.J., Adams D., Harries R.H., Cooter R.D., Belford D.A., et al. Mitogenic bovine whey extract modulates matrix metalloproteinase-2, -9, and tissue inhibitor of matrix metalloproteinase-2 levels in chronic leg ulcers. Wound Repair Regen 14 (2006) 28-37
22. Edwards J.V., Batiste S.L., Gibbins E.M., and Goheen S.C. Synthesis and activity of NH2- and COOH-terminal elastase recognition sequences on cotton. J Pept Res 54 (1999) 536-543
23. Edwards J.V., Yager D.R., Cohen I.K., Diegelmann R.F., Montante S., Bertoniere N., et al. Modified cotton gauze dressings that selectively absorb neutrophil elastase activity in solution. Wound Repair Regen 9 (2001) 50-58
24. Meyer-Ingold W, Eichner W, Ettner N, Schink M. Patent EP0945144; 1999.
25. Cullen B., Smith R., McCulloch E., Silcock D., and Morrison L. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen 10 (2002) 16-25
26. Cullen B., Watt P.W., Lundqvist C., Silcock D., Schmidt R.J., Bogan D., et al. The role of oxidised regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action. Int J Biochem Cell Biol 34 (2002) 1544-1556
27. Buchholz F., and Graham A. Modern superabsorbent polymer technology (1998), John Wiley & Sons, Inc, 605 Third Ave, New York, NY 10016, US
28. Smola-Hess S., Schnitzler R., Hadaschik D., Smola H., Mauch C., Krieg T., et al. CD40L induces matrix-metalloproteinase-9 but not tissue inhibitor of metalloproteinases-1 in cervical carcinoma cells: imbalance between NF-kappaB and STAT3 activation. Exp Cell Res 267 (2001) 205-215
29. Lauer-Fields J.L., Sritharan T., Stack M.S., Nagase H., and Fields G.B. Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9. J Biol Chem 278 (2003) 18140-18145
30. Yager D.R., and Nwomeh B.C. The proteolytic environment of chronic wounds. Wound Repair Regen 7 (1999) 433-441
31. Grinnell F., and Zhu M. Fibronectin degradation in chronic wounds depends on the relative levels of elastase, alpha1-proteinase inhibitor, and alpha2-macroglobulin. J Invest Dermatol 106 (1996) 335-341
32. Imai K., Hiramatsu A., Fukushima D., Pierschbacher M.D., and Okada Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 322 (1997) 809-814
33. Mohan R., Chintala S.K., Jung J.C., Villar W.V., McCabe F., Russo L.A., et al. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem 277 (2002) 2065-2072
34. Courderot-Masuyer C., Robin S., Bertrand X., and Tholon N.P.H. Behaviour of venous leg ulcer fibroblasts compared with normal fibroblasts in contact with an absorbing dressing in a model of dermal equivalent infected by Pseudomonas aeruginosa. J Invest Dermatol 126 (2006) s108
35. Eming S.A., Smola-Hess S., Kurschat P., Hirche D., Krieg T., and Smola H. A novel property of povidon-iodine: inhibition of excessive protease levels in chronic non-healing wounds. J Invest Dermatol 126 (2006) 2731-2733
36. Skog E., Arnesjo B., Troeng T., Gjores J.E., Bergljung L., Gundersen J., et al. A randomized trial comparing cadexomer iodine and standard treatment in the out-patient management of chronic venous ulcers. Br J Dermatol 109 (1983) 77-83
37. Veves A., Sheehan P., and Pham H.T. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 137 (2002) 822-827